Upload
Featured Recent Articles Topics Login Upload

Search Results for 'biosimilar'

biosimilar published presentations and documents on DocSlides.

High-resolution SPR surrogate potency assay to facilitate comparability and biosimilar studies
High-resolution SPR surrogate potency assay to facilitate comparability and biosimilar studies
by test
Veronica Fridh, GE Healthcare, Uppsala, Sweden No...
Biosimilars 2012 AIPLA Webinar
Biosimilars 2012 AIPLA Webinar
by stefany-barnette
September 25, 2012. 1. Denise. Kettelberger, PhD...
Conference Series LLC
Conference Series LLC
by alida-meadow
Conferences. Conference Series LLC . is a pioneer...
FDA Approves First Biosimilar Sandozs Zarxio By Jennif
FDA Approves First Biosimilar Sandozs Zarxio By Jennif
by pamella-moone
Dienes Maria E Doukas Christopher J Betti PhD ...
Biosimilar biological productEvaluation by the FDA
Biosimilar biological productEvaluation by the FDA
by alida-meadow
oducts used to diagnose, prevent, of diseases and ...
A QUM partnership approach to regulating
A QUM partnership approach to regulating
by liane-varnes
biosimilars. in Australia. David Lim, Evan Siege...
Latin American Physician Perspectives on Biosimilars
Latin American Physician Perspectives on Biosimilars
by celsa-spraggs
Presented at the . Latin American Biologics/Biosi...
Biosimilars in emerging markets- regulatory and Commercial considerations
Biosimilars in emerging markets- regulatory and Commercial considerations
by jane-oiler
OMIC Group. Biosimilars 2104. Hyderabad. India. 2...
PSHP President’s Update
PSHP President’s Update
by myesha-ticknor
PSHP Annual Assembly. October 28, 2015. Matt Scol...
Nonproprietary Naming of Biological ProductsGuidance for IndustryUS De
Nonproprietary Naming of Biological ProductsGuidance for IndustryUS De
by anastasia
x0000x0000 x/Attxachexd /xBottxom x/BBoxx 3x014x33...
Improving Your Formulary and Denials Management
Improving Your Formulary and Denials Management
by trinity
Zinkeng Asonganyi, PharmD. Director of Pharmacy Se...
Medicare Part B Step Therapy Programs
Medicare Part B Step Therapy Programs
by elina
Page 1 of 10 UnitedHealthcare Medicare Advantag...
NEUPOGEN filgrastim
NEUPOGEN filgrastim
by gelbero
GRANIX (tbo - filgrastim), NIVESTYM (filgrastim -...
Prescription Drug Resource Center
Prescription Drug Resource Center
by roberts
Generic Drug Substitution Laws May 3 , 2019 Compi...
1 Immunogenicity The key safety issue for biosimilars
1 Immunogenicity The key safety issue for biosimilars
by gelbero
Prof. Ibrahim A. . Alsarra. Professor . of . Phar...
Challenges in Assessing Therapeutic Equivalence of
Challenges in Assessing Therapeutic Equivalence of
by thomas
Nanosimilars. Beat . Flühmann. Global Lead NBCD ....
Regulatory aspects and review
Regulatory aspects and review
by mary
of EMA authorized . biosimilars. Session “Biosim...